BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9988105)

  • 1. Effects of nitric oxide synthase inhibition on sympathetically-mediated tachycardia.
    Whalen EJ; Johnson AK; Lewis SJ
    Eur J Pharmacol; 1999 Jan; 365(2-3):217-23. PubMed ID: 9988105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic actions of systemically injected pituitary adenylate cyclase activating polypeptide-27 in the rat.
    Whalen EJ; Johnson AK; Lewis SJ
    Eur J Pharmacol; 1999 Jan; 365(2-3):205-15. PubMed ID: 9988104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of beta-adrenoceptors enhances cAMP signal transduction in vivo.
    Whalen EJ; Johnson AK; Lewis SJ
    Eur J Pharmacol; 1998 Aug; 355(2-3):189-93. PubMed ID: 9760033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use-dependent loss of active sympathetic neurogenic vasodilation after nitric oxide synthase inhibition in conscious rats. Evidence for the presence of preformed stores of nitric oxide-containing factors.
    Davisson RL; Shaffer RA; Johnson AK; Lewis SJ
    Hypertension; 1996 Sep; 28(3):347-53. PubMed ID: 8794815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of alpha-adrenoceptor-mediated pressor responses by NG-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats.
    Guc MO; Furman BL; Paratt JR
    Eur J Pharmacol; 1992 Nov; 224(1):63-9. PubMed ID: 1280596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor dysfunction after inhibition of NO synthesis.
    Whalen EJ; Johnson AK; Lewis SJ
    Hypertension; 2000 Sep; 36(3):376-82. PubMed ID: 10988268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible participation of spinal nitric oxide in the control of the blood pressure in anesthetized rats.
    del Carmen García M; Celuch SM; Adler-Graschinsky E
    Brain Res; 1997 Aug; 764(1-2):67-74. PubMed ID: 9295194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity.
    Zhang K; Mayhan WG; Patel KP
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R864-72. PubMed ID: 9321861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat.
    Bower EA; Law AC
    Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.
    García M; Morán A; Luisa Martín M; Barthelmebs M; San Román L
    Eur J Pharmacol; 2006 May; 537(1-3):126-34. PubMed ID: 16630608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha adrenoceptors and nitric oxide on cardiovascular responses in acute and chronic hypertension.
    Hong E; Larios F; Gómez-Viquez NL; Huang F; Bravo G
    J Physiol Biochem; 2011 Sep; 67(3):427-35. PubMed ID: 21494848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats.
    Abdelrahman AM; Pang CC
    Life Sci; 2002 Jul; 71(7):819-25. PubMed ID: 12074941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachyphylaxis to PACAP-27 after inhibition of NO synthesis: a loss of adenylate cyclase activation.
    Whalen EJ; Johnson AK; Lewis SJ
    Am J Physiol; 1999 Nov; 277(5 Pt 2):R1453-61. PubMed ID: 10564219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the anterior region of the third ventricle in the cardiovascular responses produced by systemic injection of a nitric oxide synthase inhibitor.
    Lewis SJ; Whalen EJ; Beltz TG; Johnson AK
    Brain Res; 1999 May; 830(1):191-4. PubMed ID: 10350574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
    Gaballa MA; Raya TE; Hoover CA; Goldman S
    Cardiovasc Res; 1999 Jun; 42(3):627-35. PubMed ID: 10533602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism.
    Jordan J; Tank J; Stoffels M; Franke G; Christensen NJ; Luft FC; Boschmann M
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2803-10. PubMed ID: 11397891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Rho-kinase-mediated prostate contractions associated with impairment of β-adrenergic-cAMP-signaling pathway by chronic nitric oxide deficiency.
    Calmasini FB; Leiria LO; Alves Junior MJ; Báu FR; Alexandre EC; Silva FH; Mónica FZ; Antunes E
    Eur J Pharmacol; 2015 Jul; 758():24-30. PubMed ID: 25835610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.